NASDAQ: CTXR
Citius Pharmaceuticals Inc Stock

Overview

Forecast Earnings Dividend Ownership

$1.77-0.15 (-7.81%)

Updated Mar 4, 2021

CTXR Price

$1.77

Fair Value Price

$2.10

Market Cap

$98.37M

52 Week Low

$0.42

52 Week High

$2.90

P/E

-3.85x

P/B

3.9x

P/S

N/A

PEG

N/A

Dividend Yield

Revenue

$0.00

Earnings

-$21.37M

Gross Margin

N/A

Operating Margin

N/A

Profit Margin

N/A

Debt to Equity

0.38

Operating Cash Flow

-$21M

Beta

0.21

Next Earnings

N/A

Ex-Dividend

N/A

Next Dividend

N/A

CTXR Overview

Zen Score

Expand Score

High

Medium

Low

Industry average

Reasons for this score

CTXR ($1.77) is undervalued by 15.84% relative to our estimate of its Fair Value price of $2.10 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety

Valuation

CTXR is good value based on its book value relative to its share price (3.9x), compared to the US market average (64.96x)

Valuation

CTXR is good value based on its book value relative to its share price (3.9x), compared to the US Biotechnology industry average (9.46x)

Valuation

CTXR News

Valuation

CTXR fair value

Fair Value of CTXR stock based on Discounted Cash Flow (DCF)

Price

$1.77

Fair Value

$2.10

Undervalued by

15.84%

CTXR ($1.77) is undervalued by 15.84% relative to our estimate of its Fair Value price of $2.10 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety

Valuation

CTXR price to earnings (PE)

For valuing profitable companies with steady earnings

Company

-3.85x

Industry

-5.79x

Market

15.24x

CTXR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company

3.9x

Industry

9.46x

Market

64.96x

CTXR is good value based on its book value relative to its share price (3.9x), compared to the US market average (64.96x)

Valuation

CTXR is good value based on its book value relative to its share price (3.9x), compared to the US Biotechnology industry average (9.46x)

Valuation

CTXR's financial health

Profit margin

Revenue

$0.0

Net Income

-$8.1M

Profit Margin

CTXR's cash and short-term investments ($4.33M) cannot cover CTXR's cash burn for the next year ($21.38M), once increasing cash burn (110.51%) is accounted for

Financials

Assets to liabilities

Assets

$35.3M

Liabilities

$9.5M

Debt to equity

0.05

CTXR's short-term assets ($5.58M) exceed its short-term liabilities ($3.55M)

Financials

CTXR's long-term liabilities ($5.96M) exceed its short-term assets ($5.58M)

Financials

CTXR's debt relative to shareholder equity (0.38) has decreased or remained constant compared to 5 years ago (-1.22)

Financials

CTXR's debt to equity ratio (0.38) is considered acceptable

Financials

Cash flow

Operating

-$9.6M

Investing

$0.0

Financing

$500.0

CTXR's cash and short-term investments ($4.33M) cannot cover CTXR's cash burn ($21.38M) for 1 year

Financials

Citius Pharmaceuticals Stock FAQ

What is Citius Pharmaceuticals's quote symbol?

(NASDAQ: CTXR) Citius Pharmaceuticals trades on the NASDAQ under the ticker symbol CTXR. Citius Pharmaceuticals stock quotes can also be displayed as NASDAQ: CTXR.

How much is Citius Pharmaceuticals's stock price per share?

(NASDAQ: CTXR) Citius Pharmaceuticals stock price per share is $1.77 today (as of Mar 4, 2021).

What is the 52 week high and low for Citius Pharmaceuticals (NASDAQ: CTXR)?

(NASDAQ: CTXR) Citius Pharmaceuticals's 52-week high was $2.90, and its 52-week low was $0.42. It is currently -38.97% from its 52-week high and 326.51% from its 52-week low.

What is Citius Pharmaceuticals's Market Cap?

(NASDAQ: CTXR) Citius Pharmaceuticals's market cap is $98.37M, as of Mar 5, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Citius Pharmaceuticals's market cap is calculated by multiplying CTXR's current stock price of $1.77 by CTXR's total outstanding shares of 55,576,996.

How much is Citius Pharmaceuticals stock worth today?

(NASDAQ: CTXR) Citius Pharmaceuticals currently has 55,576,996 outstanding shares. With Citius Pharmaceuticals stock trading at $1.77 per share, the total value of Citius Pharmaceuticals stock (market capitalization) is $98.37M.

Citius Pharmaceuticals stock was originally listed at a price of $6.10 in Jul 6, 2017. If you had invested in Citius Pharmaceuticals stock at $6.10, your return over the last 3 years would have been -70.98%, for an annualized return of -33.8%.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

CTXR Overview

Zen Score

Reasons for this score

CTXR News

Valuation

CTXR fair value

Fair Value of CTXR stock based on Discounted Cash Flow (DCF)

CTXR price to earnings (PE)

For valuing profitable companies with steady earnings

CTXR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

CTXR's financial health

Profit margin

Assets to liabilities

Cash flow

Citius Pharmaceuticals Stock FAQ

(NASDAQ: CTXR) Citius Pharmaceuticals trades on the NASDAQ under the ticker symbol CTXR. Citius Pharmaceuticals stock quotes can also be displayed as NASDAQ: CTXR.

(NASDAQ: CTXR) Citius Pharmaceuticals stock price per share is $1.77 today (as of Mar 4, 2021).

(NASDAQ: CTXR) Citius Pharmaceuticals's 52-week high was $2.90, and its 52-week low was $0.42. It is currently -38.97% from its 52-week high and 326.51% from its 52-week low.

Company

Stocks

Social